Screening protocol for TAVR- candidates
All patients being admitted with aortic valve disease or failed bioprosthesis are discussed in a multidisciplinary “heart valve board”, consisting of cardiac surgeons, cardiac anesthesiologists and cardiologists. For risk estimation, the Society of Thoracic Surgeons (STS)-Score and the EuroSCORE were used. Subsequently, patients were determined for a catheter-based procedure according to the Heart team’s decision. Informed consent was obtained from all patients.